# N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

> **NCT03492047** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 75 (actual)

## Conditions studied

- Peripheral Neuropathy Due to Chemotherapy

## Interventions

- **DIETARY_SUPPLEMENT:** low dose N-acetylcysteine
- **DIETARY_SUPPLEMENT:** high dose N-acetylcysteine
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT03492047
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-06-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2020-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03492047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03492047, "N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03492047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*